INSIGHTS ON CLINICAL TRIAL DESIGN

• Developing Community-Based And Trial-Naïve Sites: The Real ROI

  Trial-naïve sites, when supported with infrastructure, training, and network integration, represent a critical yet underused opportunity to expand patient access and accelerate recruitment.

• CNS Trials Are Difficult — Do They Have To Be?

  Clinical trials for central nervous system therapies face significant obstacles to approval, including subjective endpoints and complex patient selection. Consider a strategic approach for success.

• Why Should Site Agility Be Your Next Competitive Advantage?

  Maximize your trial agility by replacing slow, linear start-ups with parallel workflows and rapid SLAs. Partnering with agile sites secures a commercial edge and predictable timelines.

• The Future Of Patient Participation In Clinical Research

  To address challenges such as limited patient awareness, mistrust, and logistical barriers, the industry must embrace technology-driven solutions and community-centered outreach.

• Mental Health: 5 Facts About Psychedelics

  10/16/2024

  As mental health issues surge globally, especially following the COVID-19 pandemic, renewed interest in psychedelic drugs is driving research into their potential therapeutic uses.

• Overcoming Barriers To Clinical Trial Participation In Oncology

  12/3/2024

  Oncology clinical trials face unique challenges in patient recruitment and retention due to barriers such as awareness, logistical constraints, and eligibility criteria.

• Effective Study Design And Execution Of Renal And Hepatic Impairment Trials

  5/1/2026

  Master the complexities of renal and hepatic trials by leveraging site expertise and PK modeling to navigate recruitment challenges and ensure precise dosing for impaired populations.

• Breaking Barriers In Drug Development: Time, Trust And Putting Patients First

  1/16/2025

  Unpack systemic challenges in drug development that inflate costs and delay life-saving treatments. Learn about streamlining processes, fostering patient trust, and reallocating resources efficiently.

• Patient Liaison Support In Rare Disease Trials

  2/11/2026

  Real stories from rare disease trials show how attentive communication, logistical coordination, and timely reimbursement reduce stress for participants while keeping long-term engagement.